- LATEST
- WEBSTORY
- TRENDING
WORLD
Oxford makes BIG statement over vaccines as Omicron concerns grow globally
Earlier on Tuesday, the head of drugmaker Moderna said that COVID-19 shots were unlikely to be as effective against the variant, jolting global market
Updated : Dec 01, 2021, 10:56 AM IST
 "Oxform makes BIG statement over vaccines as Omicron concerns grow globally")
TRENDING NOW
)
This 'small' film was rejected by 5 directors, was declared flop before release, became sleeper hit, earned Rs 70 crore
)
Meet IAS officer who had 57 postings in 33 years, with just 5 months to retire he has been assigned key role in...
)
Despite getting married to Sobhita Dhulipala, Naga Chaitanya retains romantic poster with ex-wife Samantha Ruth Prabhu
)
Kareena Kapoor rolls her eyes at Abhishek Bachchan at an event in viral video, netizens say 'this is curse of...'
)
Shillong Teer Results TODAY December 4, 2024 Live Updates: Check lucky winning numbers, prize money
)
Vikrant Massey breaks silence on his 'retirement' announcement, says his post was misread: 'I'm not...'
)
'My life is not fairytale...': Aishwarya Rai's statement goes viral amid divorce rumours with Abhishek Bachchan
)
Govinda's daughter on actor's 'toxic' relationship with Krushna Abhishek, reacts to their reunion: 'I don't speak...'
)
Vikrant Massey retires from acting: A look at his net worth, iconic roles, family life
)
Bryan Johnson, age-reversing millionaire, visits Mukesh Ambani's Antilia, shares pic with Shloka Mehta
)
Watch: Sachin Tendulkar reunites with childhood friend Vinod Kambli, netizens say, 'how life...'
)
Pushpa 2 first review out: Allu Arjun, Rashmika Mandanna impress but Fahadh Faasil leaves...
)
Sobhita Dhulipala to continue working in films after marriage? Naga Chaitanya says 'Like every Telugu household...'
)
Sanjay Dutt's premium Scotch whisky brand makes record sales in 7 months, it is priced at Rs...
)
Revealed! Here's why Vikrant Massey decided to retire from acting, insider says 'his fear is that...'
The University of Oxford on Tuesday said there was no evidence that vaccines would not prevent severe disease from Omicron, but that it was ready to rapidly develop an updated version of its vaccine developed with AstraZeneca (AZN.L) if necessary.
Earlier on Tuesday, the head of drugmaker Moderna said that COVID-19 shots were unlikely to be as effective against the variant, jolting global markets.
The University of Oxford said that there was limited data on Omicron so far, and that it would carefully evaluate the impact of the variant on its shot, echoing an AstraZeneca statement last week.
"Despite the appearance of new variants over the past year, vaccines have continued to provide very high levels of protection against severe disease and there is no evidence so far that Omicron is any different," it said in a statement.
"However, we have the necessary tools and processes in place for rapid development of an updated COVID-19 vaccine if it should be necessary."
